Clinical effectiveness and cost-effectiveness of physiotherapy and occupational therapy versus no therapy in mild to moderate Parkinson’s disease: a large pragmatic randomised controlled trial (PD REHAB)

Clarke, Carl E, Patel, Smitaa, Ives, Natalie, Rick, Caroline E, Woolley, Rebecca, Wheatley, Keith, Walker, Marion F, Zhu, Shihua, Kandiyali, Rebecca, Yao, Guiqing, Sackley, Catherine M, on behalf of the PD REHAB Collaborative Group·2016·Health Technology Assessment
DOI 10.3310/hta20630

Cited by (107)

Items 101–107 of 107

  1. A neoteric annotation on the advances in combination therapy for Parkinson’s disease: nanocarrier-based combination approach and future anticipation. Part I: exploring theoretical insights and pharmacological advances
    Devika Unnithan, Ali Sartaj, M. Iqubal, J. Ali, S. Baboota · 2024 · Expert Opinion on Drug Delivery
  2. Risk of Parkinsons Disease in Stroke Survivors: A Nationwide Cohort Study in South Korea
    H. L. Choi, J. H. Ahn, W. H. Chang, W. Jung, J. Youn, D. Shin · 2023 · medRxiv
  3. PARKİNSON HASTALARININ İŞ BIRAKMA NEDENLERİNİN İNCELENMESİ
    Gamze Ertürk, Semra Oğuz, M. G. Polat, Sibel Ertan · 2022 · Türk Fizyoterapi ve Rehabilitasyon Dergisi
  4. Novel missense mitochondrial DNA 4079A>G variation in familial early-onset Parkinson’s disease
    S. Andalib, T. Mousavi, E. Sakhinia, B. Jabbari · 2018 · Basal Ganglia
  5. Physio- und Ergotherapie können die Lebensqualität nicht verbessern
    G. Deuschl · 2016 · InFo Neurologie & Psychiatrie
  6. "Analysis of the Associated Mutations of DJ-1 Gene to Parkinson’s Patients in Vietnam"
    Duc Minh Nguyen, Hieu Duc Nguyen, H. Giang, Leiwang Long, N. N. Minh, T. Võ · 2020
  7. Pathophysiologic Insights from Biomarker Studies in Neurological Disorders
    M. Moccia · 2020 · Frontiers Research Topics